Nuclear receptor-driven alterations in bile acid and lipid metabolic pathways during gestation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 8, 2011, Pages 879-887

  Papacleovoulou, Georgia ^a   Abu Hayyeh, Shadi ^a   Williamson, Catherine ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bile acids; Cholestasis; Metabolism; Nuclear receptors; Oestrogens; Pregnancy

Indexed keywords

ANDROGEN RECEPTOR; BILE ACID; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROGESTERONE RECEPTOR; THYROID HORMONE RECEPTOR;

BILE ACID METABOLISM; CHOLESTASIS; FETOPLACENTAL UNIT; FETUS DEVELOPMENT; GENE EXPRESSION; HUMAN; LIPID METABOLISM; LIVER FUNCTION; LIVER TOXICITY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BILE ACIDS AND SALTS; CIRCADIAN RHYTHM; ESTROGENS; FEMALE; GENE EXPRESSION; HUMANS; LIPID METABOLISM; LIVER; MICE; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 79958245908     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.11.001     Document Type: Review

References (96)

1. Smith R.W. The effects of pregnancy and lactation on the activities in rat liver of some enzymes associated with glucose metabolism. Biochim Biophys Acta (BBA)-general subjects 1975, 411:22-29.
2. Tracy T., Venkataramanan R., Glover D., Caritis S.N. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 2005, 192:633-639.
3. Smith J.L., Lear S.R., Forte T.M., Ko W., Massimi M., Erickson S.K. Effect of pregnancy and lactation on lipoprotein and cholesterol metabolism in the rat. J Lipid Res 1998, 39:2237-2249.
4. Belo L., Caslake M., Santos-Silva A., Castro E.M.B., Pereira-Leite L., Quintanilha A., Rebelo I. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004, 177:391-399.
5. P.M. Catalano, E.D. Tyzbir, R.R. Wolfe, N.M. Roman, S.B. Amini, E.A. Sims, Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women, Am J Obstet Gynecol 167 (1992) 913-919.
6. Milona A., Owen B.M., van Mil S., Dormann D., Mataki C., Boudjelal M., Cairns W., Schoonjans K., Milligan S., Parker M., White R., Williamson C. The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr. Am J Physiol Gastrointest Liver Physiol 2010, 298:G151-158.
7. Hollister A., Okubara P., Watson J.G., Chaykin S. Reproduction in mice: liver enlargement in mice during pregnancy and lactation. Life Sci 1987, 40:11-18.
8. Bustamante J.J., Copple B.L., Soares M.J., Dai G. Gene profiling of maternal hepatic adaptations to pregnancy. Liver International 2010, 30:406-415.
9. Freemark M. Regulation of maternal metabolism by pituitary and placental hormones: roles in fetal development and metabolic programming. Hormone Res in Paediatr 2006, 65:41-49.
10. Castano G., Lucangioli S., Sookoian S., Mesquida M., Lemberg A., Di Scala M., Franchi P., Carducci C., Tripodi V. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci 2006, 110:459-465.
11. Maglich J., Sluder A., Guan X., Shi Y., McKee D., Carrick K., Kamdar K., Willson T., Moore J. Comparison of complete nuclear receptor sets from the human. Caenorhabditis elegans and Drosophila genomes, Genome Biol 2001, 2. research0029.0021-research0029.0027.
12. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 1988, 240:889-895.
13. Sonoda J., Pei L., Evans R.M. Nuclear receptors: decoding metabolic disease. FEBS Letters 2008, 582:2-9.
14. Giguere V. Orphan nuclear receptors: from gene to function. Endocr Rev 1999, 20:689-725.
15. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
16. Rees D.C., Johnson E., Lewinson O. ABC transporters: the power to change. Nat Rev Mol Cell Biol 2009, 10:218-227.
17. Waxman D.J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR. PXR, and PPAR, Arch Biochem Biophys 1999, 369:11-23.
18. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., Mangelsdorf D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000, 6:507-515.
19. Lai K., Harnish D.C., Evans M.J. Estrogen receptor α regulates expression of the orphan receptor small heterodimer partner. J Biol Chem 2003, 278:36418-36429.
20. Harding H.P., Lazar M.A. The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol 1995, 15:4791-4802.
21. Yin L., Wu N., Curtin J.C., Qatanani M., Szwergold N.R., Reid R.A., Waitt G.M., Parks D.J., Pearce K.H., Wisely G.B., Lazar M.A. Rev-erb{alpha}, a heme sensor that coordinates metabolic and circadian pathways. Science 2007, 318:1786-1789.
22. Raghuram S., Stayrook K.R., Huang P., Rogers P.M., Nosie A.K., McClure D.B., Burris L.L., Khorasanizadeh S., Burris T.P., Rastinejad F. 19 Identification of heme as the ligand for the orphan nuclear receptors REVERBalpha and REV-ERBbeta. Nat Struct Mol Biol 2007, 14:1207-1213.
23. Mataki C., Magnier B.C., Houten S.M., Annicotte J.S., Argmann C., Thomas C., Overmars H., Kulik W., Metzger D., Auwerx J., Schoonjans K. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol 2007, 27:8330-8339.
24. Bolotin E., Liao H., Chi Ta T., Yang C., Hwang-Verslues W., Evans R.J., Jiang T., Sladek F.M. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 2010, 51:642-653.
25. Huang J., Iqbal J., Saha P.K., Liu J., Chan L., Hussain M.M., Moore D.D., Wang L. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 2007, 46:147-157.
26. Le Martelot G., Claudel T., Gatfield D., Schaad O., Kornmann B., Sasso G.L., Moschetta A., Schibler U. REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol 2009, 7:e1000181.
27. Duez H., van der Veen J.N., Duhem C., Pourcet B., Touvier T., Fontaine C., Derudas B., Baugé E., Havinga R., Bloks V.W., Wolters H., van der Sluijs F.H., Vennstrom B., Kuipers F., Staels B. Regulation of bile acid synthesis by the nuclear receptor Rev-erb [alpha]. Gastroenterology 2008, 135:689-698.
28. Sweeney T.R., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am J Physiol Endocrinol Metab 2006, 290:E1313-1320.
29. He X.J., Yamauchi H., Suzuki K., Ueno M., Nakayama H., Doi K. Gene expression profiles of drug-metabolizing enzymes (DMEs) in rat liver during pregnancy and lactation. Experim Molec Pathol 2007, 83:428-434.
30. O'Sullivan A.J., Martin A., Brown M.A. Efficient fat storage in premenopausal women and in early pregnancy: a role for estrogen. J Clin Endocrinol Metab 2001, 86:4951-4956.
31. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
32. A. Foryst-Ludwig, U. Kintscher, Metabolic impact of estrogen signalling through ERalpha and ERbeta, The Journal of Steroid Biochemistry and Molecular Biology In Press, Uncorrected Proof (2010).
33. Ribas V., Nguyen M.T.A., Henstridge D.C., Nguyen A.-K., Beaven S.W., Watt M.J., Hevener A.L. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ER{alpha}-deficient mice. Am J Physiol Endocrinol Metab 2009, 298:E304-319.
34. G.E. Dressing, J.E. Goldberg, N.J. Charles, K.L. Schwertfeger, C.A. Lange, Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications, Steroids, In Press, Corrected Proof (2010).
35. Yamamoto Y., Moore R., Hess H.A., Guo G.L., Gonzalez F.J., Korach K.S., Maronpot R.R., Negishi M. Estrogen receptor α mediates 17α-ethynylestradiol causing hepatotoxicity. J Biol Chem 2006, 281:16625-16631.
36. Simon F.R., Fortune J., Iwahashi M., Qadri I., Sutherland E. Multihormonal regulation of hepatic sinusoidal Ntcp gene expression. Am J Physiol Gastrointest Liver Physiol 2004, 287:G782-794.
37. Henriquez-Hernandez L.A., Flores-Morales A., Santana-Farrre R., Axelson M., Nilsson P., Norstedt G., Fernandez-Perez L. Role of pituitary hormones on 17α-ethinylestradiol-induced cholestasis in rat. J Pharmacol Experim Therap 2007, 320:695-705.
38. Vallejo M., Briz O., Serrano M.A., Monte M.J., Marin J.J.G. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy. J Hepatol 2006, 44:1150-1157.
39. Abu-Hayyeh S., Martinez-Becerra P., Sheikh Abdul S.H. Kadir, C. Selden, M.R. Romero, M. Rees, H.-U. Marschall, J.J.G. Marin, C. Williamson, Inhibition of Na+-taurocholate co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites. J Biol Chem 2010, 285:16504-16512.
40. Byrne J.A., Strautnieks S.S., Mieli-Vergani G., Higgins C.F., Linton K.J., Thompson R.J. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 2002, 123:1649-1658.
41. Noe J., Stieger B., Meier P.J. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002, 123:1659-1666.
42. Gerloff T., Geier A., Roots I., Meier P.J., Gartung C. Functional analysis of the rat bile salt export pump gene promoter. Eur J Biochem 2002, 269:3495-3503.
43. Hata S., Wang P., Eftychiou N., Ananthanarayanan M., Batta A., Salen G., Pang K.S., Wolkoff A.W. Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am J Physiol Gastrointest Liver Physiol 2003, 285:G829-839.
44. Kouzuki H., Suzuki H., Ito K., Ohashi R., Sugiyama Y. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes. J Pharmacol Experim Therap 1998, 286:1043-1050.
45. Denson L.A., Sturm E., Echevarria W., Zimmerman T.L., Makishima M., Mangelsdorf D.J., Karpen S.J. The orphan nuclear receptor, shp, mediates bile acid-Induced Inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001, 121:140-147.
46. Boaglio A.C., Zucchetti A.E., Sanchez Pozzi E.J., Pellegrino J.M., Ochoa J.E., Mottino A.D., Vore M., Crocenzi F.A., Roma M.G. Phosphoinositide 3- kinase/protein kinase B signaling pathway is involved in estradiol 17beta-d-glucuronide-induced cholestasis: complementarity with classical protein kinase c. Hepatology 2010.
47. Crocenzi F.A., Mottino A.D., Cao J., Veggi L.M., Pozzi E.J.S., Vore M., Coleman R., Roma M.G. Estradiol-17{beta}-d-glucuronide induces endocytic internalization of Bsep in rats. Am J Physiol Gastrointest Liver Physiol 2003, 285:G449-459.
48. Mottino A.D., Cao J., Veggi L.M., Crocenzi F., Roma M.G., Vore M. Altered localization and activity of canalicular Mrp2 in estradiol-17beta-dglucuronide- induced cholestasis. Hepatology 2002, 35:1409-1419.
49. Green R.M., Hoda F., Ward K.L. Molecular cloning and characterization of the murine bile salt export pump. Gene 2000, 241:117-123.
50. Geier A., Dietrich C.G., Gerloff T., Haendly J., Kullak-Ublick G.A., Stieger B., Meier P.J., Matern S., Gartung C. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim Biophys Acta (BBA) - Biomembranes 2003, 1609:87-94.
51. Mottino A.D., Crocenzi F.A., Pozzi E.J.S., Veggi L.M., Roma M.G., Vore M. Role of microtubules in estradiol-17{beta}-d-glucuronide-induced alteration of canalicular Mrp2 localization and activity. Am J Physiol Gastrointest Liver Physiol 2005, 288:G327-336.
52. Milona A., Owen B.M., Cobbold J.F., Willemsen E.C., Cox I.J., Boudjelal M., Cairns W., Schoonjans K., Taylor-Robinson S.D., Klomp L.W., Parker M.G., White R., van Mil S.W., Williamson C. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 2010, 52:1341-1349.
53. Leuenberger N., Pradervand S., Wahli W. Sumoylated PPARα mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. J of Clin Invest 2009, 119:3138-3148.
54. Butte N.F. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000, 71:1256S-1261.
55. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000, 6:517-526.
56. Ananthanarayanan M., Balasubramanian N., Makishima M., Mangelsdorf D.J., Suchy F.J. Human bile salt export pump promoter Is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 2001, 276:28857-28865.
57. Huang L., Zhao A., Lew J.-L., Zhang T., Hrywna Y., Thompson J.R., de Pedro N., Royo I., Blevins R.A., Pelaez F., Wright S.D., Cui J. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 2003, 278:51085-51090.
58. Landrier J.F., Eloranta J.J., Vavricka S.R., Kullak-Ublick G.A. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-{alpha} and -beta genes. Am J Physiol Gastrointest Liver Physiol 2006, 290:G476-485.
59. Kitada H., Miyata M., Nakamura T., Tozawa A., Honma W., Shimada M., Nagata K., Sinal C.J., Guo G.L., Gonzalez F.J., Yamazoe Y. Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J Biol Chem 2003, 278:17838-17844.
60. Leung K.C., Johannsson G., Leong G.M., Ho K.K.Y. Estrogen regulation of growth hormone action. Endocr Rev 2004, 25:693-721.
61. Umetani M., Domoto H., Gormley A.K., Yuhanna I.S., Cummins C.L., Javitt N.B., Korach K.S., Shaul P.W., Mangelsdorf D.J. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med 2007, 13:1185-1192.
62. Riddick D.S., Lee C., Bhathena A., Timsit Y.E., Cheng P.-Y., Morgan E.T., Prough R.A., Ripp S.L., Miller K.K.M., Jahan A., Chiang J.Y.L. Transcriptional 22 suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab Dispos 2004, 32:367-375.
63. Paschkis K.E., Cantarow A. Pregnancy, tumor growth, and liver regeneration. Cancer Res 1958, 18:1060-1066.
64. Dai G., He L., Bu P., Wan Y.J. Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology 2008, 47:1277-1287.
65. Huang W., Ma K., Zhang J., Qatanani M., Cuvillier J., Liu J., Dong B., Huang X., Moore D.D. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312:233-236.
66. Gielchinsky Y., Laufer N., Weitman E., Abramovitch R., Granot Z., Bergman Y., Pikarsky E. Pregnancy restores the regenerative capacity of the aged liver via activation of an mTORC1-controlled hyperplasia/hypertrophy switch. Genes Dev 2010, 24:543-548.
67. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 2008, 47:376-379.
68. Reyes H., Gonzalez M.C., Ribalta J., Aburto H., Matus C., Schramm G., Katz R., Medina E. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978, 88:487-493.
69. Geenes V., Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009, 15:2049-2066.
70. Glantz A., Marschall H.U., Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40:467-474.
71. Dixon P.H., Weerasekera N., Linton K.J., Donaldson O., Chambers J., Egginton E., Weaver J., Nelson-Piercy C., Swiet M.d., Warnes G., Elias E., Higgins C.F., Johnston D.G., McCarthy M.I., Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000, 9:1209-1217.
72. Mullenbach R., Linton K.J., Wiltshire S., Weerasekera N., Chambers J., Elias E., Higgins C.F., Johnston D.G., McCarthy M.I., Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. Journal of Medical Genetics 2003, 40:e70.
73. Dixon P.H., van Mil S.W.C., Chambers J., Strautnieks S., Thompson R.J., Lammert F., Kubitz R., Keitel V., Glantz A., Mattsson L.-Ö., Marschall H.-U., Molokhia M., Moore G.E., Linton K.J., Williamson C. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009, 58:537-544.
74. van Mil S.W., Milona A., Dixon P.H., Mullenbach R., Geenes V., Chambers J., Shevchuk V., Moore G.E., Lammert F., Glantz A.G., Mattsson L., Whittaker J., Parker M.G., White R., Williamson C. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007, 133:507-516.
75. Sookoian S., Castano G., Burgueno A., Gianotti T.F., Pirola C.J. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol 2008, 48:125-132.
76. Kern F., Everson G.T., DeMark B., McKinley C., Showalter R., Erfling W., Braverman D.Z., Szczepanik-van Leeuwen P., Klein P.D. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle, J Clin Invest 1981, 68:1229-1242.
77. Owen B.M., Van Mil S.W., Boudjelal M., McLay I., Cairns W., Elias E., White R., Williamson C., Dixon P.H. Sequencing and functional assessment of hPXR (NR1I2) variants in intrahepatic cholestasis of pregnancy. Xenobiotica 2008, 38:1289-1297.
78. Castaño G., Burgueño A., Fernández Gianotti T., Pirola C.J. The influence of common gene variants of the xenobiotic receptor PXR in genetic susceptibility to intrahepatic cholestasis of pregnancy. Alimentary Pharmacology & Therapeutics 2010, 31:583-592.
79. Kawamoto T., Kakizaki S., Yoshinari K., Negishi M. Estrogen activation of the nuclear orphan receptor CAR (Constitutive Active Receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 2000, 14:1897-1905.
80. Kliewer S.A., Moore J.T., Wade L., Staudinger J.L., Watson M.A., Jones S.A., McKee D.D., Oliver B.B., Willson T.M., Zetterstrom R.H., Perlmann T., Lehmann J.r.M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998, 92:73-82.
81. Hagedorn K.A., Cooke C.-L., Falck J.R., Mitchell B.F., Davidge S.T. Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor. Hypertension 2007, 49:328-333.
82. Kancheva R., Hill M., Cibula D., Vcelakova H., Kancheva L., Vrbikova J., Fait T., Parizek A., Starka L. Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy. J Endocrinol 2007, 195:67-78.
83. Levitz M., Young B.K. Estrogens in pregnancy. Vitam Horm 1977, 35:109-147.
84. Wei P., Zhang J., Egan-Hafley M., Liang S., Moore D.D. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000, 407:920-923.
85. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998, 102:1016-1023.
86. Aye I.L.M.H., Waddell B.J., Mark P.J., Keelan J.A. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity. Biochim Biophys Acta (BBA) - Molecular and Cell Biology of Lipids 2010, 1801:1013-1024.
87. Marceau G., Volle D.H., Gallot D., Mangelsdorf D.J., Sapin V., Lobaccaro J.M. Placental expression of the nuclear receptors for oxysterols LXRalpha and LXRbeta during mouse and human development. Anat Rec A Discov Mol Cell Evol Biol 2005, 283:175-181.
88. Pavan L., Hermouet A., Tsatsaris V., Therond P., Sawamura T., Evain- Brion D., Fournier T. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 2004, 145:4583-4591.
89. Stefulj J., Panzenboeck U., Becker T., Hirschmugl B., Schweinzer C., Lang I., Marsche G., Sadjak A., Lang U., Desoye G., Wadsack C. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res 2009, 104:600-608.
90. M.S. Weedon-Fekjér, G.M. Johnsen, E.H. Anthonisen, M. Sugulle, H.I. Nebb, A.K. Duttaroy, A.C. Staff, Expression of liver X receptors in pregnancies complicated by preeclampsia, Placenta In Press, Corrected Proof (2010).
91. Mouzat K., Prod'homme M., Volle D.H., Sion B., Dechelotte P., Gauthier K., Vanacker J.M., Lobaccaro J.M. Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J Biol Chem 2007, 282:4693-4701.
92. Serrano M.A., Macias R.I.R., Briz O., Monte M.J., Blazquez A.G., Williamson C., Kubitz R., Marin J.J.G. Expression in human trophoblast and choriocarcinoma cell Lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 2007, 28:107-117.
93. Ma K., Xiao R., Tseng H.T., Shan L., Fu L., Moore D.D. Circadian dysregulation disrupts bile acid homeostasis. PLoS One 2009, 4:e6843.
94. Nakamura T.J., Moriya T., Inoue S., Shimazoe T., Watanabe S., Ebihara S., Shinohara K. Estrogen differentially regulates expression of Per1 and Per2 genes between central and peripheral clocks and between reproductive and nonreproductive tissues in female rats. Journal of Neuroscience Research 2005, 82:622-630.
95. Shechter A., Varin F., Boivin D.B. Circadian variation of sleep during the follicular and luteal phases of the menstrual cycle. Sleep 2010, 33:647-656.
96. Pennington C.R., Ross P.E., Murison J., Bouchier I.A. Fluctuations of serum bile acid concentrations during the menstrual cycle. J Clin Pathol 1981, 34:185-186.